For example, TMPRSS2-ERG gene fusion is an early driver event in almost half of prostate cancer cases, and it often co-exists with copy number loss of PTEN and NKX3-1 [5–7]. This evidence concerns the gene TMPRSS2 and prostate carcinoma.